Germline Mutation of <i>Bap1</i> Accelerates Development of Asbestos-Induced Malignant Mesothelioma

  • Jinfei Xu
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Yuwaraj Kadariya
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Mitchell Cheung
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Jianming Pei
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Jacqueline Talarchek
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Eleonora Sementino
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Yinfei Tan
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Craig W. Menges
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Kathy Q. Cai
    2Department of Pathology, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Samuel Litwin
    3Biostatistics and Bioinformatics Facility, Fox Chase Cancer Center, Philadelphia, Pennsylvania.
  • Hongzhuang Peng
    4Gene Expression and Regulation, Wistar Institute, Philadelphia, Pennsylvania.
  • Jayashree Karar
    4Gene Expression and Regulation, Wistar Institute, Philadelphia, Pennsylvania.
  • Frank J. Rauscher
    4Gene Expression and Regulation, Wistar Institute, Philadelphia, Pennsylvania.
  • Joseph R. Testa
    1Cancer Biology Program, Fox Chase Cancer Center, Philadelphia, Pennsylvania.

書誌事項

公開日
2014-08-13
DOI
  • 10.1158/0008-5472.can-14-1328
公開者
American Association for Cancer Research (AACR)

この論文をさがす

説明

<jats:title>Abstract</jats:title> <jats:p>Malignant mesotheliomas are highly aggressive tumors usually caused by exposure to asbestos. Germline-inactivating mutations of BAP1 predispose to mesothelioma and certain other cancers. However, why mesothelioma is the predominate malignancy in some BAP1 families and not others, and whether exposure to asbestos is required for development of mesothelioma in BAP1 mutation carriers are not known. To address these questions experimentally, we generated a Bap1+/− knockout mouse model to assess its susceptibility to mesothelioma upon chronic exposure to asbestos. Bap1+/− mice exhibited a significantly higher incidence of asbestos-induced mesothelioma than wild-type (WT) littermates (73% vs. 32%, respectively). Furthermore, mesotheliomas arose at an accelerated rate in Bap1+/− mice than in WT animals (median survival, 43 weeks vs. 55 weeks after initial exposure, respectively) and showed increased invasiveness and proliferation. No spontaneous mesotheliomas were seen in unexposed Bap1+/− mice followed for up to 87 weeks of age. Mesothelioma cells from Bap1+/− mice showed biallelic inactivation of Bap1, consistent with its proposed role as a recessive cancer susceptibility gene. Unlike in WT mice, mesotheliomas from Bap1+/− mice did not require homozygous loss of Cdkn2a. However, normal mesothelial cells and mesothelioma cells from Bap1+/− mice showed downregulation of Rb through a p16(Ink4a)-independent mechanism, suggesting that predisposition of Bap1+/− mice to mesothelioma may be facilitated, in part, by cooperation between Bap1 and Rb. Drawing parallels to human disease, these unbiased genetic findings indicate that BAP1 mutation carriers are predisposed to the tumorigenic effects of asbestos and suggest that high penetrance of mesothelioma requires such environmental exposure. Cancer Res; 74(16); 4388–97. ©2014 AACR.</jats:p>

収録刊行物

  • Cancer Research

    Cancer Research 74 (16), 4388-4397, 2014-08-13

    American Association for Cancer Research (AACR)

被引用文献 (3)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ